GeoVax and Vaxeal to Collaborate on Cancer Immunotherapy Program – GlobeNewswire (press release)
|
GeoVax and Vaxeal to Collaborate on Cancer Immunotherapy Program
GlobeNewswire (press release) ATLANTA, GA, Jan. 03, 2018 (GLOBE NEWSWIRE) — GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that it is collaborating with Vaxeal Holding SA on the expansion of GeoVax's cancer immunotherapy program … |
